Prince Pharmaceutical Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	96.32	-53.54	15.31	51.55	-8.3
Depreciation & Amortization	61.61	62.49	58.56	52.35	45.34
Other Amortization	-	-	-	-	0.88
Loss (Gain) From Sale of Assets	0.17	0.14	-0.06	-0.06	-0.09
Stock-Based Compensation	0.91	9.32	6.27	2.93	-
Provision & Write-off of Bad Debts	0.01	-	-0.1	0.08	0.02
Other Operating Activities	8.33	-3.01	3.74	12.65	-0.03
Change in Accounts Receivable	-80.51	-8.44	-32.4	-3.72	-14.86
Change in Inventory	-64.09	0.65	7.74	-24.42	-32.09
Change in Accounts Payable	46.96	23.23	29.47	-13.09	29
Change in Unearned Revenue	-1.15	2.83	-12.17	3.87	-
Change in Other Net Operating Assets	21.49	12.55	-13.87	9.51	22.49
Operating Cash Flow	90.06	46.21	62.5	91.65	42.36
Operating Cash Flow Growth	94.89%	-26.07%	-31.81%	116.38%	-
Capital Expenditures	-18.24	-18	-62.05	-19.53	-40.98
Sale of Property, Plant & Equipment	0.07	1.14	0.06	0.06	0.12
Sale (Purchase) of Intangibles	-0.56	-	-0.19	-0.28	-0.3
Other Investing Activities	-0.8	-0.46	-5.82	-20.27	2.36
Investing Cash Flow	-19.54	-17.32	-68.01	-40.02	-38.79
Long-Term Debt Issued	-	-	-	-	68.45
Short-Term Debt Repaid	-	-	-	-30	-45
Long-Term Debt Repaid	-40.51	-39.5	-38.7	-22.17	-11.59
Total Debt Repaid	-40.51	-39.5	-38.7	-52.17	-56.59
Net Debt Issued (Repaid)	-40.51	-39.5	-38.7	-52.17	11.86
Issuance of Common Stock	19.8	-	100.24	-	-
Common Dividends Paid	-	-9.15	-5.43	-	-
Financing Cash Flow	-20.7	-48.65	56.11	-52.17	11.86
Net Cash Flow	49.81	-19.76	50.61	-0.54	15.42
Free Cash Flow	71.81	28.21	0.45	72.13	1.38
Free Cash Flow Growth	154.56%	6197.10%	-99.38%	5118.96%	-
Free Cash Flow Margin	6.80%	4.09%	0.06%	10.12%	0.31%
Free Cash Flow Per Share	1.95	0.77	0.01	2.16	0.04
Cash Interest Paid	-	10.27	10.46	8.92	5.59
Cash Income Tax Paid	-	4.46	0.11	0.02	-0.01
Levered Free Cash Flow	37.7	42.18	-3.52	46.01	4.07
Unlevered Free Cash Flow	43.69	48.59	3.02	51.6	8.79
Change in Working Capital	-77.3	30.81	-21.22	-27.85	4.54

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.